key: cord-0886856-1qnwi5s7 authors: Alexandersen, S.; Chamings, A.; Bhatta, T. R. title: SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication date: 2020-06-05 journal: nan DOI: 10.1101/2020.06.01.20119750 sha: 9d0f43a9c974fc85762e34678fea6cd5826efa57 doc_id: 886856 cord_uid: 1qnwi5s7 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in China in late December 2019 and has spread worldwide. Coronaviruses are enveloped, positive sense, single-stranded RNA viruses and employ a complicated pattern of virus genome length RNA replication as well as transcription of genome length and leader containing subgenomic RNAs. Although not fully understood, both replication and transcription are thought to take place in so-called double-membrane vesicles in the cytoplasm of infected cells. We here describe detection of SARS-CoV-2 subgenomic RNAs in diagnostic samples up to 17 days after initial detection of infection, and provide a likely explanation not only for extended PCR positivity of such samples, but also for discrepancies in results of different PCR methods described by others. Overall, we present evidence that subgenomic RNAs may not be an indicator of active coronavirus replication/infection, but that these RNAs, similar to the virus genome RNA, may be rather stable, and thus detectable for an extended period, most likely due to their close association with cellular membranes. ribosomal frameshift between Orf1a and 1b, and proteolytic processing of the generated polyproteins, and translated from the full length plus sense virus genome RNA. As mentioned, a set of subgenomic RNAs are also generated, most likely from a complex mechanism involving paused negative sense RNA synthesis leading to a nested set of negative sense RNAs from the 3'end of the virus genome joined to a common 5'-leader sequence of approximately 70 nucleotides 7 . These nested negative sense RNAs in turn serve as templates for generation of plus strands thus able to serve as a nested set of virus mRNAs for translation of specific proteins from the 3'-third of the virus genome 7 . These subgenomic mRNAs of SARS-CoV-2 are thought to encode the following virus proteins: structural proteins spike (S), envelope (E), membrane (M) and nucleocapsid protein (N) and several accessory proteins for SARS-CoV-2 thought to include 3a, 6, 7a, 7b, 8 and 10 8 . The mechanism for generation of these subgenomic mRNAs, are not fully understood 7, 9 , but thought to be tightly regulated to ensure the optimal ratio of virus proteins and to involve pausing of the virus replication/transcription complex at so-called transcription-regulatory sequences (TRS) located immediately adjacent to open reading frames for these virus genes 8 . Furthermore, it appears that the expression of the N protein is required for efficient coronavirus subgenomic mRNA transcription 7 . The subcellular site/s of coronavirus RNA replication and transcription in the cytoplasm of infected cells is not fully defined, but thought to involve so-called "double-membrane vesicles" (DMV) in or on which the virus replication complex synthesise the needed double and single stranded full length genomic and subgenomic RNAs 7, 9 . While it is still unclear whether this RNA synthesis takes place inside or on the outside of these vesicles, it is thought that the membranes somehow "protect" the synthesised RNA, including double stranded RNA, from host cell recognition and response and also from experimental exposure to RNase 9, 10 . In addition, it has been shown that coronavirus cytosolic RNA is protected from so-called "nonsense-mediated decay" (NMD) by the virus N protein and thus are more stable in that environment compared to what would have been expected for non-spliced RNA 11 . Finally, while it was originally thought that coronavirus virions contained subgenomic RNAs in addition to the virus plus strand genomic length RNA, it has now been shown that these subgenomic RNAs do not contain a packaging signal and are not found in highly purified, cellular membrane free, coronavirus virions 12 . However, this further indicates, that unless specific steps to remove cellular membranes are used for sample preparation, such coronavirus RNAs are tightly associated with membrane structures, and interestingly, appear to be found in a consistent ratio of around 1-8 to 1 as compared to virus genomic RNA 13 . As mentioned above, the exact mechanism for generation of coronavirus genomic and subgenomic RNAs are not fully understood, but thought to involve the virus replication complex, the TRS, the N protein and double-membrane vesicles in the cytoplasm of infected cells. Although one study has been published looking at the abundance of subgenomic RNAs for SARS-Cov-2, that study employed virus culture in Vero cells 8 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint in sputum samples from day 4-9 of infection, but only up to day 5 in throat swab samples 14 . However, while that study assumed a correlation between the presence of the subgenomic E mRNA and active virus replication/transcription and thus active infection, this assumption may not be accurate considering what has been mentioned above about the membrane associated nature of coronavirus RNA and their stability/protection from the host cell response and from RNases. We here describe the detection of SARS-CoV-2 subgenomic RNAs in routine diagnostic oropharyngeal/nasopharyngeal swabs subjected to next generation sequencing (NGS) and extend the study to also look at subgenomic RNAs being present in selected read archives selected from the NCBI Sequence Read Archive. We show that such subgenomic RNAs are present in most samples, but that the overall, and individual, subgenomic RNA abundance varies among samples and may be related to stage of infection and, importantly, more related to how samples were taken and treated before testing/sequencing. In turn, this finding may help explain the extended period of PCR positivity observed in infected individuals and also, at least in part, explain conflicting findings around "reinfection" as well as discrepancies among diagnostic PCRs detecting targets in different parts of the SARS-CoV-2 genome 15, 16 . Table 1 . Overall, of the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint 56 million NGS reads generated from the 14 virus-positive samples, nearly 800,000 reads mapped to one of the 10 SARS-CoV-2 subgenomic RNAs (Table 1A) . However, no reads mapped to the tentative Orf10/15 RNA and only 5 reads were mapped to the tentative Orf7b RNA. In contrast, reads were mapped to the other 8 subgenomic RNAs, and although it differed among samples, S (Spike) were consistently mapped at a low level followed in increasing order by subgenomic RNAs for Orf3A, E, M and Orf6. Orf7a, Orf8 and N were mapped in the highest abundance although, as mentioned, this was not consistent for all samples (Table 1B and Figures 1-2). As indicated above, the abundance, although overall more or less as expected based on assumed subgenomic RNA abundance [7] [8] [9] 13, 17 (Table 1) , clearly shows the preference for amplification of subgenomic RNAs from short read length samples (Fig 3 and Table 1 , comparing good quality samples 35 and 36 with relatively poor quality samples 62, 63 and 64). To look further into this, we analysed the mapping results of two samples already known to be of poor quality, having been suspended in water rather than PBS/transport medium before coming to our laboratory. Although these two samples had a low Ct (high virus load) in the PCR, the NGS generated mostly very short reads (Sample 65 and 68, Table 1 ) and had a different pattern with a very high abundance of subgenomic RNAs dominated by the Orf7a subgenomic amplicon ( Supplementary Fig. S4 , samples 65 and 68). As mentioned, this is most likely due to this amplicon being short (sequence length between leader sequence forward primer and nearest pool 2 reverse primer of only 85 nucleotides, although most other subgenomic amplicons would also be expected to be . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint short (supplementary Table S1 ). Our sample set analysed here also included samples from two individuals sampled 11-17 days apart and representing early and late infection; sample 37 early and sample 60 late and sample 62 even later (poor quality) as well as sample 38 early and sample 61 late as well as sample 63 (poor quality) taken in between samples 38 and sample 61. As can be seen in the comparison of these samples ( Supplementary Fig. S5 ), the levels of subgenomic RNAs detected are higher in the late infection samples than in the early ones. Although this may possibly indicate a rather long period of virus replication/transcription, we believe it to be more likely due to coronavirus membrane-associated RNAs being partly, albeit not fully, protected from host and environmental degradation and that samples with partly degraded RNA, represented as shorter average read lengths, have some short subgenomic RNA amplicons preferentially amplified (Table 1 and Fig. 4 ), and thus, as mentioned, more consistent with such samples mainly containing partly degraded virus genomic as well as subgenomic RNAs. To validate our results detailed above, we looked at the NGS reads to find likely subgenomic RNAs already mapped to the virus genome but filtering so only reads containing part of the leader sequence were included and then look at where these reads had been mapped. Between . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint The samples with the highest number of reads mapping to cryptic or unknown TRS were the poorer quality samples 34, 64 and 65 and no consistent pattern was observed in the mapping of reads with the leader sequence to any individual unrecognised TRS site. The final step in our analysis included searching the NCBI SRA and selection of a few deposited NGS reads from studies using either the same SARS-CoV-2 Ampliseq panel used by us as well as a few generated by different methods, such as direct RNAseq or even virus RNA targeted capture (virus RNA targeted capture SRX8336076; Ion Torrent RNAseq e.g. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint ORF7a (7.1%), followed by ORF3a (1.7%) and M gene (1.2%). The subgenomic S gene and ORF6 were typically low (0.1% and 0.9% respectively). No reads were mapped to the subgenomic ORF10 in any sample, and only sample SRR11267570 and SRR11810737 had any reads mapped to the subgenomic ORF7b (0.2-0.3% of reads having the leader sequence). We here describe the specific detection and mapping of SARS-CoV-2 leader-containing subgenomic RNAs in routine diagnostic oropharyngeal/nasopharyngeal swabs subjected to next generation sequencing (NGS). We present results from two different approaches to map subgenomic RNAs and extend the analysis to also look at subgenomic RNAs being present in Although subgenomic RNAs are thought to be particular abundant in early infection, reportedly up to 70 times more abundant than virus genomic RNA at the peak of RNA transcription, that may only be observed in cell culture, as it occurs as early as 6-8 hours after infection 18 and after that is found at a more steady state level of a ratio of 1:1-1:8 13 . Our specific detection of subgenomic RNAs in clinical samples and the indication that these RNAs are rather stable and most likely found in, and protected by, membrane structures and that their relative abundance may be more related to sample quality and storage before testing/sequencing than to the actual stage of infection, may help explain not only the extended period of PCR positivity observed in infected individuals, but also, at least in part, help explain conflicting findings around "reinfection" as well as discrepancies among diagnostic PCRs detecting targets in different parts of the SARS-CoV-2 genome 15, 16 . For example, our analysis . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint indicated that some subgenomic RNAs may be more abundantly detected in poor samples, possibly because of partly degraded RNA in such samples and the increased ability of PCR, including most diagnostic PCRs as well as NGS employing various amplification steps, to amplify short targets. We believe that this is particular evident in the Ampliseq and other multi primer-pair sequencing strategies, because partly degraded targets will increase amplification of short amplicons as the "competition" with longer target amplicons is decreased. This notion is supported by our findings in inadvertently poor samples, in our sample material represented by two diagnostic samples that for unrelated reasons had been suspended in water rather than in PBS or transport medium as for our other samples. These particular two samples (sample 65 and 68, Table 1 ), in which cells and membrane vesicles were almost certainly disrupted 19 , and thus any coronavirus RNAs exposed to the environment and likely to RNases, were dominated by short reads, i.e. short amplicons, and strikingly, with a very high abundance of reads mapped to subgenomic RNAs, in particular the Orf7a RNA. Clearly, original sample abundance cannot change just because cellular membranes are lysed by the hypotonic treatment, so the observed increase in these reads may almost certainly be caused by preferred amplification of shorter or more efficient amplicons in such samples. Nevertheless, taken together, it shows that these subgenomic RNAs are present in our diagnostic samples, but that relative ratios are highly dependent on sample handling. Our mapping of specific subgenomic RNAs indicated that samples had no or very low levels of subgenomic RNA specific for Orf7b and that a subgenomic RNA specific for Orf10/15 was absent. This is consistent with what has been described for SARS-CoV-2 in cell culture 8 . A recent publication 20 did report conflicting results for diagnostic samples; however, we believe this to be due to misinterpretation of the results of that study, as NGS reads of only 75 nucleotides in length were mapped to the SARS-CoV-2 genome and assigned to subgenomic RNA regions, completely ignoring the fact that only leader containing reads would be specific for any given subgenomic RNA. Consequently, their interpretation of high levels of e.g. Orf10 is most likely incorrect, and their data simply a reflection of a higher coverage of the 3'-end of the genome which is expected as all subgenomic RNAs extend to the 3'-end of the virus genome. However, the apparent coverage observed in that study is approximately 8 times higher towards the 3'-end, consistent with what would be expected in diagnostic material with virus RNAs protected by cellular membranes 10, 13 and consistent with the overall abundance of subgenomic RNAs observed in our study. Nevertheless, we emphasise that these studies are . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint not comparable, as we believe the study described by Zhang et al. 20 is not mapping subgenomic RNAs but simply reports coverage for the different parts of the virus genome. That coronaviruses, and their RNA, may be extremely resistant when part of a membrane matrix is well known, and was demonstrated for example when another coronavirus, the porcine epidemic diarrhea virus, entered and infected pigs in Canada in early 2014 by feed containing spray-dried porcine plasma 21, 22 . Detergent treatment and ultracentrifugation indicated that this coronavirus RNA was initially bound to membranes, but could be pelleted by ultracentrifugation after detergent release and other studies, e.g. our own using yet another coronavirus, the avian infectious bronchitis virus, further support that detergent treatment will release the coronavirus RNA and make it susceptible to nuclease degradation while passing through 0.8, but not 0.45 micron filtres, support the fact that the majority of such coronavirus RNA is membrane bound 23 . Consequently, we believe that the methods described here to detect and look at relative abundance of SARS-CoV-2 RNAs in clinical samples together with insights in what is known about coronavirus cell biology overall, will have general interest and applicability not only for SARS-CoV-2, but also for other coronaviruses and related viruses. We here describe extended analysis of samples already subjected to next generation sequencing For the studies described here we added one additional positive sample collected on the 24 th of April 2020. This sample was subjected to NGS in exactly the same way as described for the samples mentioned above (details of methods given in (submitted to the Journal Viruses)). For the study described here we also included additional negative controls, including some samples In addition to analysis of the NGS reads obtained from the samples mentioned above, we also searched the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) and used selected SRA studies to support the findings from our own samples. Nucleic acid extraction and cDNA synthesis was performed as described including heating extracted nucleic acids at 70°C for 5 minutes and rapid cooling on ice before cDNA synthesis using SuperScript™ VILO™ Master Mix (Thermofisher Scientific, Victoria, Australia) as per manufacturers' instructions and described previously (submitted to the Journal Viruses) 24 . Prepared cDNA samples were then amplified using the Ion Ampliseq™ Library Kit 2.0 (Thermofisher Scientific, Victoria, Australia) as described earlier 25, 26 and a commercially available SARS-CoV-2 Ampliseq panel kindly provided by Thermofisher Scientific, Victoria, Australia. In addition, two of the samples that yielded a low virus coverage by this method, were amplified separately using essentially the same method, but with the Ampliseq Hi Fi mix replaced with Amplitaq Gold 360 Master mix for the amplification step. Amplification was done for either 21, 27 or 35 cycles depending on the estimated virus load in the samples as described previously (submitted to the Journal Viruses) and libraries prepared and run on Ion Torrent 530 chips on an Ion S5 XL genetic sequencer (Thermofisher Scientific) at a concentration of 50pM as per the manufacturer's protocols and as described previously (submitted to the Journal Viruses) 24, 27 . As described previously (submitted to the Journal Viruses), generated sequence reads were then mapped to a SARS-CoV-2 reference genome . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint using the TMAP software included in the Torrent Suite 5.10.1 28 , and virus genomic consensus sequences generated using additional Torrent Suite plugins supplied by Thermofisher Scientific, and visualized in Integrative Genomic Viewer 29 (IGV 2.6.3) (Broad Institute, Cambridge, MA, USA). Near complete and partial SARS-CoV-2 genomes were aligned using Clustal-W 30 in MEGA 7 software 31 and near full length sequences submitted to the Global Initiative on Sharing All influenza Database (GISAID) 32,33 (https://www.gisaid.org/) as described in our previous study (submitted to the Journal Viruses). Although the SARS-CoV-2 Ampliseq panel used for the NGS has been designed to generate Consequently, we concluded that the Ampliseq panel used here would potentially also amplify SARS-CoV-2 subgenomic RNAs by amplification from these two forward primers together with the closest downstream primer included in the same Ampliseq pool. Although this was not evident when assembling full virus genome sequences (submitted to the Journal Viruses), a close inspection of reads around expected subgenomic RNA Transcription Regulatory Sites (TRS) 17 indicated that a significant number of NGS reads may have been amplified from subgenomic RNAs rather than from virus genomic RNA. To analyse this in more detail, we first assembled an exploratory composite reference for remapping using the Torrent Suite Tmap reanalyse function. This initial assembled reference consisted of a composite reference with one sequence containing the first 21500 nucleotides of the SARS-CoV-2 genome used for the initial assembly (NCBI Accession MN908947.3) 2 to map reads most likely corresponding to the virus genome while we in addition, assembled 10 tentative subgenomic RNA sequences containing 28 nucleotides from the 3'end of the leader sequence (of which the first 11 nucleotides would be from the forward primer from primer pool 2, if not enzymatically . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint removed by the NGS process) and this leader then followed by the assumed TRS and gene specific sequence for the next 72 nucleotides. Consequently, this reference contained the first 21500 nucleotides of the virus genome as well as 10 composite references corresponding to the assumed 5'-end of the 10 potential subgenomic RNAs; S, Orf3a, E, M, Orf6, Orf7a, Orf7b, Orf8, N and Orf10/15 7, 8, 17 . This initial analysis indicated that this was an efficient way of mapping reads corresponding to subgenomic RNAs, and for our final analysis we updated the subgenomic RNA sequences in this composite reference to include the full leader sequence from nucleotide 1-69 and extended the gene specific sequences to ensure that they would include a reverse primer from each primer pool without extending into the next specific gene is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint position of the leader mapped to the reference genome, each read was assigned to the corresponding subgenomic TRS. Typically, the leader sequence sat within a soft-clipped portion of each read, although depending on the reference sequence, the Ion Torrent TMAP algorithm did occasionally include the start of the leader sequence within the mapped portion of some reads, and at times included spurious insertions or deletions within this section of the mapping in its attempt to map the leader to the reference. Therefore, any read with the leader ending within 10nt of the start of the known subgenomic TRS sequences were assigned to the respective TRS. Some reads did not map to any known TRS, and these were assigned to an "Unknown TRS". The final step in our analysis included searching the NCBI SRA from where we selected a few deposited NGS reads from studies using the same SARS-CoV-2 Ampliseq panel used by us and in addition selected a few generated by different methods. SAM files from 15 SRA accessions were downloaded with the NCBI SRAtoolkit sam-dump 2.8.2 and mapped to the Ampliseq SARS-CoV-2 reference MN908947.3 2 using NCBI Magic-BLAST 1.3.0 with a minimum alignment score of 50 and percentage identity of 90% or higher. The script and analysis method to identify reads containing the leader sequence described above was used on the Magic-BLAST mapped SAM files for each of the SRA archives, and the number of reads corresponding to the start of each subgenomic RNA tallied. Further information on research design is available in the Nature Research Reporting Summary linked to this article. The sequence reads and the subgenomic RNA mapping file for our SARS-CoV-2 positive . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint Figure 1 . Average coverage per 5 million reads for the samples included in this study and mapped to either the virus genome or to each subgenomic RNA. The sample is shown on the X-axis and the coverage/number of reads on the Y-axis. Reads mapped to the individual subgenomic RNAs in the fasta file used for mapping are indicated with different colours. Figure 2 . Shows essentially the same data as Fig. 1 , but with the different genomic or subgenomic RNAs on the X-axis and the coverage/number of mapped reads per 5 million reads on the Y-axis. Different samples are indicated with different colours. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint Supplementary Materials: The following is available online; Supplementary Information file S1, Supplementary Tables S1-S3 and Supplementary Figures S1-S7. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.01.20119750 doi: medRxiv preprint The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China A new coronavirus associated with human respiratory disease in China A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster An interactive web-based dashboard to track COVID-19 in real time The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 A new coronavirus associated with human respiratory disease in China Continuous and discontinuous RNA synthesis in coronaviruses The architecture of SARS-CoV-2 transcriptome A unifying structural and functional model of the coronavirus replication organelle: tracking down RNA synthesis Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture Interplay between coronavirus, a cytoplasmic RNA virus, and nonsense-mediated mRNA decay pathway Transmissible gastroenteritis coronavirus packaging signal is located at the 5' end of the virus genome Presence of subgenomic mRNAs in virions of coronavirus IBV Virological assessment of hospitalized patients with COVID-2019 To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients Coronavirus SARS-CoV-2: Analysis of subgenomic mRNA transcription, 3CLpro and PL2pro protease cleavage sites and protein synthesis Subgenomic messenger RNA amplification in coronaviruses Mechanism of spontaneous insideout vesiculation of red cell membranes Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling The first case of porcine epidemic diarrhea in Canada Investigation into the role of potentially contaminated feed as a source of the first-detected outbreaks of porcine epidemic diarrhea in Canada Metagenomics detection and characterisation of viruses in faecal samples from Australian wild birds Detection and characterisation of canine astrovirus, canine parvovirus and canine papillomavirus in puppies using next generation sequencing Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017-18 Australian epidemic Evolutionary and network analysis of virus sequences from infants infected with an Australian recombinant strain of human parechovirus type 3 Detection of a Reassortant H9N2 Avian Influenza Virus with Intercontinental Gene Segments in a Resident Australian Chestnut Teal Comparison of mapping algorithms used in high-throughput sequencing: application to Ion Torrent data Integrative Genomics Viewer (IGV): highperformance genomics data visualization and exploration Clustal W and Clustal X version 2.0 MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets Data, disease and diplomacy: GISAID's innovative contribution to global health Global initiative on sharing all influenza data-from vision to reality The Sequence Alignment/Map format and SAMtools We acknowledge clinical and laboratory diagnostic staff for providing samples and for doing the initial diagnostic SARS-CoV-2 testing. We gratefully acknowledge Thermofisher Scientific, Victoria, Australia, for supplying the Ampliseq panel used. We also acknowledge Jason Hodge, laboratory manager of the GCEID laboratory for his technical input. Finally, we gratefully acknowledge the authors and originating and submitting laboratories for the sequence read archives we have used in this study (Supplementary Table S3 ). Orf10 33 153 6 432 15 57 77 99 60 261 0 42 174 0 34 73 1.2 312 8 29 98 63 58 592 0 250 35 0 35 149 1.6 96 1 17 17 9 14 72 0 17 81 0 36 163 1.3 6 0 4 0 0 1 1 0 1 1 0 37 185 5.2 26840 243 6798 5691 5548 6551 12898 0 1539 33261 0 38 184 3.3 16640 179 2464 1715 1702 1587 4107 0 406 5071 0 60 0 0 512 4 3738 0 0 0 0 0 64 92 3 927 0 0 0 147 0 15680 0 1753 6610 0 65 84 5.1 2502 2 10 16256 1225 16328 155642 0 11755 1805 0 66 207 14.3 28310 563 6190 6351 2026 2471 6798 0 282 7048 0 67